Global Drug Discovery Informatics Market Growth, Share, Size, Trends and Forecast (2024 - 2030)

By Function;

Sequencing & Target Data Analysis, Docking, Molecular Modelling, Libraries & Database Preparation, and Others.

By Solution;

Software, and Services.

By End User;

Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), and Others.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa, and Latin America - Report Timeline (2020 - 2030).
Report ID: Rn158393864 Published Date: October, 2024 Updated Date: December, 2024

Introduction

Global Drug Discovery Informatics Market (USD Million), 2020 - 2030

In the year 2023, the Global Drug Discovery Informatics Market was valued at USD 3,447.62 million. The size of this market is expected to increase to USD 6,528.39 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 9.6%.

The drug discovery informatics market is witnessing significant growth propelled by advancements in computational technologies, increasing adoption of in-silico modeling techniques, and rising demand for efficient drug discovery processes. Drug discovery informatics involves the application of computational methods and software tools to streamline the drug discovery and development process, from target identification to lead optimization. These informatics solutions play a crucial role in accelerating the pace of drug discovery, reducing costs, and improving success rates by enabling researchers to analyze large datasets, predict drug-target interactions, and prioritize candidate compounds more effectively.

One of the key drivers fueling the growth of the drug discovery informatics market is the growing emphasis on personalized medicine and precision therapeutics. With the advent of genomics, proteomics, and other -omics technologies, there is a wealth of biological data available for analysis, necessitating sophisticated informatics solutions to derive actionable insights. Drug discovery informatics platforms enable researchers to integrate and analyze diverse datasets, identify disease biomarkers, and develop targeted therapies tailored to individual patient profiles, thereby revolutionizing the drug development paradigm and enhancing patient outcomes.

The increasing adoption of artificial intelligence (AI) and machine learning (ML) algorithms is reshaping drug discovery informatics, enabling more accurate predictions and faster decision-making. AI-driven informatics platforms can analyze vast amounts of data, identify complex patterns, and generate novel hypotheses, accelerating the drug discovery process. By leveraging AI and ML capabilities, pharmaceutical companies and research institutions can expedite lead identification, optimize drug candidates, and navigate the complex regulatory landscape more efficiently, driving innovation and competitiveness in the market.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Function
    2. Market Snapshot, By Solution
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Global Drug Discovery Informatics Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing R&D Investments
        2. Growing Demand for Personalized Medicine
        3. Expanding Drug Pipeline and Therapeutic Areas
      2. Restraints
        1. Integration and Interoperability Challenges
        2. High Cost of Implementation and Maintenance
        3. Data Quality and Standardization Issues
      3. Opportunities
        1. Increasing Focus on Personalized Medicine
        2. Expansion of Outsourcing Activities
        3. Integration of Omics Data
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Drug Discovery Informatics Market, By Function, 2020 - 2030 (USD Million)
      1. Sequencing & Target Data Analysis
      2. Docking
      3. Molecular Modelling
      4. Libraries & Database Preparation
      5. Others
    2. Global Drug Discovery Informatics Market, By Solution, 2020 - 2030 (USD Million)
      1. Software
      2. Services
    3. Global Drug Discovery Informatics Market, By End User, 2020 - 2030 (USD Million)
      1. Pharmaceutical and Biotechnology Companies
      2. Contract Research Organizations (CROS)
      3. Others
    4. Global Drug Discovery Informatics Market, By Geography, 2020 - 2030 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Collaborative Drug Discovery
      2. Dassault Systmes
      3. GVK Biosciences
      4. IBM Infosys
      5. IO Informatics
      6. Jubilant Life Sciences
      7. Novo Informatics
      8. Perkinelmer
      9. Thermo Fisher Scientific
  7. Analyst Views
  8. Future Outlook of the Market